Beamtree Holdings Limited (ASX:BMT – Get Rating) insider Michael (Mike) Hill bought 52,245 shares of Beamtree stock in a transaction dated Thursday, March 9th. The stock was acquired at an average price of A$0.28 ($0.19) per share, with a total value of A$14,785.34 ($9,856.89).
Beamtree Price Performance
The company has a debt-to-equity ratio of 1.99, a current ratio of 0.83 and a quick ratio of 1.49.
Get
Beamtree alerts:
About Beamtree
(Get Rating)
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data.
Featured Articles
- Dollar General Offers Great Prices, but the Stock isn't a Value
- Jabil Inc.: Blue Chip Tech Stock Pulls Back To Buy Zone
- Should You Bring The Luck Of The Irish To Your Investmets?
- The Big Banks Join Forces to Save First Republic Bank
- Don't Miss Out: $2 Trillion Could be Headed to the Banking Sector
Receive News & Ratings for Beamtree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beamtree and related companies with MarketBeat.com's FREE daily email newsletter.
Beamtree Holdings Limited(澳大利亚证券交易所代码:BMT-GET Rating)内部人士迈克尔·Mike·希尔在一笔日期为3月9日星期四的交易中购买了52,245股Beamtree股票。该股的收购均价为每股0.28澳元(0.19美元),总价值为14,785.34澳元(9,856.89美元)。
波束树性价比
该公司的债务权益比为1.99,流动比率为0.83,速动比率为1.49。
到达
波束树警报:
关于Beamtree
(获取评级)
Beamtree Holdings Limited向澳大利亚和国际医疗行业开发和商业化临床决策支持(CDS)系统。该公司提供RippleDown Expert,这是一种CDS系统,提供实时患者监测和警报解决方案;RippleDown Auditor,自动实时审查数据,确保数据输入、账单、样本接收和标记可疑错误的准确性;以及Picq,这是一种用于公立和私立医院、卫生服务和州卫生部门的编码质量评估工具,用于评估和报告临床编码数据。
专题文章
- 美元通用提供了很好的价格,但股票不是价值
- 捷普公司:蓝筹股科技股回落至买入区
- 你应该把爱尔兰人的幸运带给你的投资者吗?
- 大银行联手拯救First Republic Bank
- 不要错过预期:2万亿美元可能流向银行业
接受Beamtree Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Beamtree和相关公司的最新新闻和分析师评级的每日简要摘要。